Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced the appointment of Dr Michael Murray as Chair of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback